Several forms of dyslipidemia are associated with premature coronary a
rtery disease (CAD) and other vascular disease. These include elevated
low-density lipoprotein cholesterol, low levels of high-density lipop
rotein cholesterol, and elevated triglyceride. Because of the high inc
idence of CAD in many Western countries, including the United States,
guidelines for managing dyslipidemia and reducing the risk of CAD have
been promulgated. The National Cholesterol Education Program (NCEP) o
f the National Institutes of Health recently released revised guidelin
es for the treatment of adults with dyslipidemia, as did the European
Atherosclerosis Society. Although the two reports differ in emphasis,
both recommend routine screening of adults to identify specific indivi
duals at high risk for future CAD events.